Pathnostics

Pathnostics is a leading precision diagnostic testing and development company based in Irvine, California. Founded in 2011, the company employs 181 individuals and generates an annual revenue of $100 million. Pathnostics specializes in providing solutions for infectious disease and cancer diagnostics, with a focus on delivering accurate and timely results to help guide patient care. Their flagship product, the Guidance® UTI diagnostic test, is designed for the management of complicated, recurrent, or persistent urinary tract infections (UTIs) and patients at elevated risk. Guidance UTI combines polymerase chain reaction (PCR) testing with their proprietary Pooled Antibiotic Susceptibility Testing™ (P-AST™) technology to provide personalized treatment recommendations within a day. The Guidance UTI test offers physicians a comprehensive understanding of the causative pathogens and their antibiotic susceptibilities, enabling them to make more informed treatment decisions. This approach promotes antibiotic stewardship and helps ensure patients receive the most effective therapy from the outset. For more information about Pathnostics and their advanced diagnostic solutions, please visit their website at pathnostics.com.